Evidence map›Paper›PMID 23326156›Full record

ArticleWorld journal of gastroenterology2013

Tumor-infiltrating B cells come into vogue.

Michael Linnebacher

Abstract readComment
In one paragraph

Article in World journal of gastroenterology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Michael LinnebacherDivision of Molecular Oncology and Immunotherapy, Department of General Surgery, University of Rostock, D-18057 Rostock, Germany. michael.linnebacher@med.uni-rostock.de

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lymphocyte infiltration into solid tumors has been recognized as a main determinator of positive prognosis. For the most part this is attributed to cytotoxic T cells capable of directly destroying malignant cells. However, when considering the complex composition of the human immune system, recent findings of Nielsen et al on a potentially central role of tumor-infiltrating B cells is not really surprising. In this commentary article, I want to highlight the enormous potential impact of this observation for basic and translational research, prognostic procedures and ultimately for the development of future therapeutic concepts.

Indexed as

Cytotoxicity, ImmunologicAntigens, CD20B-LymphocytesCD8-Positive T-LymphocytesFemaleHumansLymphocytes, Tumor-InfiltratingOvarian NeoplasmsTumor Necrosis Factor Receptor Superfamily, Member 7Antigens, CD20Tumor Necrosis Factor Receptor Superfamily, Member 7CD20+ tumor-infiltrating lymphocytesFunctional immunologyImmunotherapyPrognosisTumor-infiltrating B cells

Identifiers

PMID23326156
PMCPMC3542760

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.